Biotech News
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value
investors.senseibio.com2026-05-06 15:13 EST
BOSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that its Board of Directors has determined, after extensive